Study | Reason for exclusion |
---|---|
Althaus 2015 | Ineligible comparator |
Aman 1997 | Non‐RCT |
Aman 2009 | Ineligible comparator |
Anderson 1984 | Focus not on unwanted behaviours (irritability, aggression, self‐injury) |
Anderson 1989 | Focus not on unwanted behaviours (irritability, aggression, self‐injury) |
Anderson 1997 | Non‐RCT |
Anderson 2007 | Ineligible outcomes |
Arman 2003 | Non‐RCT |
Arnold 2012b | Ineligible comparator |
August 1987 | Focused on core symptoms of ASD |
Bachmann 2013 | Non‐RCT |
Barnard‐Brak 2016 | Non‐RCT |
Beeghly 1987 | Focused on core symptoms of ASD |
Castellanos 2019 | Foccused on core symptoms of ASD |
Chez 2002 | Non‐pharmacological |
Chez 2003 | Focused on core symptoms of ASD |
Du 2015 | Focused on core symptoms of ASD |
Duker 1991 | Focused on core symptoms of ASD |
Dunn‐Geier 2000 | Focused on core symptoms of ASD |
Ekman 1989 | Focused on core symptoms of ASD |
Fahmy 2013 | Focused on core symptoms of ASD |
Fang 2018 | Non‐pharmacological intervention (e.g. herbal etc.) |
Findling 1997a | Non‐pharmacological intervention (e.g. herbal etc.) |
Groden 1987 | Non‐RCT |
Guglielmo 2013 | Non‐RCT |
Handen 2013 | Did not focus on BoC |
Hellings 2006a | Non‐RCT |
Hellings 2010 | Non‐RCT |
Hellings 2015 | Non‐RCT |
Hess 2010 | Non‐RCT |
Hollander 2003 | Focus not on BoC |
Hollander 2006c | Did not focus on people with ASD |
Hollander 2020c | Retracted study |
Horovitz 2012 | Non‐RCT |
Horrigan 1997 | Non‐RCT |
Hughes 2002 | Non‐RCT |
Jacob 2020 | Terminated study |
Jordan 2012 | Non‐RCT |
JPRN‐UMIN000007250 2012 | Terminated study |
Jun 2000 | Focused on core symptoms of ASD |
Kolmen 1995 | Focused on core symptoms of ASD |
Kolmen 1997 | Non‐RCT |
Krusch 2004 | Focus not on BoC |
Leboyer 1993 | Non‐RCT |
Lemonnier 2012 | Focused on core symptoms of ASD |
Leventhal 1993 | Focus not on BoC (irritability, aggression, self‐injury) |
Levine 1997 | Non‐RCT |
Malone 2002 | Non‐RCT |
Moharreri 2017 | Focused on core symptoms of ASD |
Nagaraj 2006 | Scales ineligible and AEs were not specified for each group |
NCT00198120 2005 | Focused on lethargy and improvement in CGI |
NCT01078844 | Terminated study |
Nickels 2008 | Non‐RCT |
Niederhofer 2007 | Non‐RCT |
Posey 2004 | Focused on core symptoms of ASD |
Preckel 2016 | Focused on core symptoms of ASD |
Purdon 1994 | Non‐RCT |
Radzivil 2006 | Non‐RCT |
Ratcliff‐Schaub 2005 | Focus not on BoC (irritability, aggression, self‐injury) |
Ritvo 1971 | Non‐RCT |
Ritvo 1983 | Non‐RCT |
Ritvo 1984 | Non‐RCT |
Roberts 2001 | Focus not on BoC (irritability, aggression, self‐injury) |
Scifo 1996 | Ineligible outcomes |
Sponheim 2002 | Focus not on BoC (irritability, aggression, self‐injury) |
Steiner 1999 | Focus not on BoC (irritability, aggression, self‐injury) |
Stubbs 1986 | Focus not on BoC (irritability, aggression, self‐injury) |
Sugie 2003 | Non‐RCT |
Sugiyama 1998 | Ineligible outcomes and measures used were not specific to BoC (e.g. CGI) |
Tachibana 2013 | Non‐RCT |
Taylor 1993 | Did not focus on people with ASD |
Tolbert 1993 | Ineligible outcomes |
Troost 2006 | Non‐RCT |
Volkmar 1983 | Non‐RCT |
Volkmar 2009 | Ineligible study design |
Wasserman 2005 | Focus not on BoC |
Wei 2011 | Non‐RCT |
Witwer 2005 | Did not focus on BoC |
Yarbrough 1987 | Outcomes ‐ insufficient data reported |
Yui 2012 | Focus not on BoC (irritability, aggression, self‐injury) |
Zingarelli 1992 | Non‐RCT |
ABC‐I: Aberrant Behaviour Checklist (Irritability subscale); AE: adverse effect; ASD: autism spectrum disorder; BoC: behaviours of concern; CGI: Clinical Global Impression; RCT: randomised controlled trial